
Press Releases
- Gadopiclenol Marketing Authorization Dossier Submissions Accepted For Review By EMA and FDA
- Guerbet Expands Portfolio with Microcatheters and Guidewires for Interventional Imaging and Embolization
- Guerbet Announces Appointment Of Jared Houk As Commercial Vice President For North America
- Top Medical Imaging Company and Provider of Diagnostic Imaging Collaborate to Elevate Patient Experience and Lower Cost of Care
- Guerbet Reports Recording-Breaking Demand for Dotarem
- Hydra Vision Awarded Vizient Contract
- Guerbet Announces Key Research and Educational Grants and Partnerships
- Guerbet provides 100 academic scholarships for students
- Top Medical Imaging Company Welcomes Top Sales & Marketing Leader (1)
- Guerbet To Showcase Its UNIK Solution At RSNA 2020
- US FDA Approves Guerbet's Optiray® (Ioversol Injection) Imaging Bulk Package
- Guerbet Announces FDA Approval For U.S. Dotarem (gadoterate meglumine) Injection Production
- American Board Of Artificial Intelligence In Medicine Aims To Educate And Certify Healthcare Professionals In AI
- Guerbet Announces Appointment Of Thomas Mclaughlin As Vice President Of North America
- Guerbet Announces Group Purchasing Agreement With Premier To Distribute Novel Microcatheters
- Lipiodol Transitions From Temporary Importation To Regular Supply
- Guerbet To Showcase Ongoing Collaboration With IBM Watson
Media Relations
Guerbet North America
US (877) 729-6679